Real-world performance of Lumipulse G plasma p-tau217: a six-month experience of a specialized clinical neurochemistry laboratory
Burak Arslan(University of Gothenburg), Henrik Zetterberg(University of Wisconsin–Madison), Andréa Lessa Benedet(McGill University Health Centre), Hanna Fahlén(Sahlgrenska University Hospital), Johan Gobom(Sahlgrenska University Hospital), Joel Simrén(University of Gothenburg), Ulf Andreasson(Sahlgrenska University Hospital), Hlin Kvartsberg(University of Gothenburg)
Cited by 1
Related Papers
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2021|354
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
|Alzheimer s & Dementia|2021|238
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
|Acta Neuropathologica|2022|229
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years
|Brain Communications|2022|187